Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Home Infusion Therapy Corporate Milestones

Date : 28 May 2026

Latest Updates of Companies in the Home Infusion Therapy Market

Home Infusion Therapy Market Companies are Coram CVS Health , Optum Infusion Services, KabaFusion, Baxter International, B. Braun Melsungen

Company Headquarters Latest Update
Coram CVS Health United States Coram CVS/specialty infusion services is a subsidiary of CVS Health, specializing in home infusion and enteral nutrition treatment.
Optum Infusion Services United States Optum grows its limited distribution drug network, increasing the opportunity to serve more patients with complex and rare diseases.
KabaFusion United States In February 2026, KabaFusion, a nationally recognized leader in home and alternative site infusion, and Nautic Partners announced that Nautic has completed its growth spending in KabaFusion.
Baxter International United States In April 2026, Baxter introduced the IV Verify line labeling system, an automated service to enhance IV labeling in medical care settings. 
B. Braun Melsungen Germany In May 2026, B. Braun Medical Inc., a recognized leader in smart infusion therapy and pharmaceutical manufacturing, announced the launch of Rocuronium Bromide Injection, the first and only FDA-approved, room-temperature-stable prefilled syringe supplied as a 50 mg/5 mL single-dose Luer lock syringe.

Recent Developments in the Home Infusion Therapy Market

  • In May 2026, Pure Infusion, a leading provider of ambulatory infusion services, announced the launch of its new brand formed via the merger of AleraCare and Pure Healthcare.
  • In May 2026, Biogen Inc. announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. Apellis, a leader in advancing treatments for serious, complement-driven diseases, is now a wholly owned subsidiary of Biogen.

Supply Chain Analysis

R&D:

  • Research and development (R&D) in home infusion therapy involves technology and pump innovation, protocol and workflow design, stability testing, and telehealth incorporation.
  • Key Players: Baxter International and Fresenius Kabi

Manufacturing Processes:

  • Major manufacturing home infusion therapy includes sterile compounding, quality assurance and testing, sterilization processes, and packaging, labeling, and delivery
  • Key Players: B. Braun Melsungen and ICU Medical

Patient Services:

  • Major patient services involve clinical coordination, medication compounding, medical devices setup, nursing care, and 24/7 monitoring.
  • Key Players: KabaFusion and Coram CVS Health

Market Growth

The global home infusion therapy market size was estimated at USD 48.72 billion in 2025 and is predicted to increase from USD 52.23 billion in 2026 to approximately USD 97.65 billion by 2035, expanding at a CAGR of 7.2% from 2026 to 2035.

Home Infusion Therapy Market Size is USD 52.23 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales